Imatinib Inhibits the Renewal and Tumorigenicity of CT-26 Colon Cancer Cells after Cytoreductive Treatment with Doxorubicin
Crossref DOI link: https://doi.org/10.1007/s00005-016-0391-0
Published Online: 2016-03-08
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Przybyszewska, Małgorzata
Miłoszewska, Joanna
Kotlarz, Agnieszka
Swoboda, Paweł
Pyśniak, Kazimiera
Szczepek, Wojciech
Kaczmarek, Łukasz
Markowicz, Sergiusz
Funding for this research was provided by:
National Science Centre, Poland (N N402 139738)
Text and Data Mining valid from 2016-03-08